Janus Henderson Group plc 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:12 pm Sale | 2024-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 10,575,363 8.500% | -346,533 (-3.17%) | Filing |
| 2024-11-14 2:53 pm Purchase | 2024-09-30 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 10,921,896 9.800% | 3,940,520 (+56.44%) | Filing |
| 2024-02-13 2:10 pm Purchase | 2023-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 6,981,376 7.300% | 1,007,237 (+16.86%) | Filing |
| 2023-02-10 12:06 pm Purchase | 2022-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 5,974,139 7.600% | 1,727,475 (+40.68%) | Filing |
| 2022-02-10 5:24 pm Purchase | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 4,246,664 8.000% | 49,886 (+1.19%) | Filing |
| 2021-02-12 3:52 pm Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | JANUS HENDERSON GROUP PLC JHG | 4,196,778 8.200% | 4,196,778 (New Position) | Filing |